close 73% van de retail rekeningen verliezen gelden met de handel in CFD`s bij deze aanbieder. Investeringen zijn risicovol en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 73% van de retail beleggers lijdt verlies bij het handelen in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

LLY

1,075.45

+0.59%↑

JNJ

205.43

-0.83%↓

ABBV

229.42

+0.51%↑

UNH

325.13

-0.09%↓

AZN

92.14

+0.68%↑

LLY

1,075.45

+0.59%↑

JNJ

205.43

-0.83%↓

ABBV

229.42

+0.51%↑

UNH

325.13

-0.09%↓

AZN

92.14

+0.68%↑

LLY

1,075.45

+0.59%↑

JNJ

205.43

-0.83%↓

ABBV

229.42

+0.51%↑

UNH

325.13

-0.09%↓

AZN

92.14

+0.68%↑

LLY

1,075.45

+0.59%↑

JNJ

205.43

-0.83%↓

ABBV

229.42

+0.51%↑

UNH

325.13

-0.09%↓

AZN

92.14

+0.68%↑

LLY

1,075.45

+0.59%↑

JNJ

205.43

-0.83%↓

ABBV

229.42

+0.51%↑

UNH

325.13

-0.09%↓

AZN

92.14

+0.68%↑

Home・Aandelen Lijst・VIRIDIAN THERAPEUTICS INC
Search

VIRIDIAN THERAPEUTICS INC

Open

SectorGezondheidszorg

32.22 -1.32

Strong Buy

Prijsupdate 23 dec 2025, 16:46 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

31.91

Max

32.86

Belangrijke statistieken

By Trading Economics

Inkomsten

66M

-35M

Verkoop

70M

71M

Winstmarge

-49.028

Werknemers

143

EBITDA

66M

-34M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+29.95% upside

Marktinformatie

By TradingEconomics

Marktkapitalisatie

997M

3.2B

Vorige openingsprijs

33.54

Vorige sluitingsprijs

32.22

Nieuwssentiment

By Acuity

50%

50%

166 / 374 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

12 / 13.14 Steun & Weerstand

VIRIDIAN THERAPEUTICS INC Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

22 dec 2025, 23:54 UTC

Belangrijke Marktbewegers

Novo Nordisk ADRs Gain on FDA Approval of First GLP-1 in Pill Form

DJ

Lezen

22 dec 2025, 19:08 UTC

Acquisities, Fusies, Overnames

Correction to Alphabet to Buy Intersect Article

DJ

Lezen

22 dec 2025, 17:21 UTC

Acquisities, Fusies, Overnames

Alphabet to Buy Intersect for $4.75 Billion as AI-Investment Plans Grow -- Update

DJ

Lezen

22 dec 2025, 16:46 UTC

Acquisities, Fusies, Overnames

Alphabet to Buy Intersect for $4.75 Billion in Cash

DJ

Lezen

22 dec 2025, 23:50 UTC

Marktinformatie

Nikkei May Decline as Yen Rebounds -- Market Talk

DJ

Lezen

22 dec 2025, 23:42 UTC

Marktinformatie

Gold Hits Record High Amid Rising Geopolitical Risks -- Market Talk

DJ

Lezen

22 dec 2025, 22:31 UTC

Winsten

Zhejiang Sanhua Intelligent Controls: Higher Demand for Air-Conditioning Components Supported Results >002050.SZ

DJ

Lezen

22 dec 2025, 22:31 UTC

Winsten

Zhejiang Sanhua Intelligent Controls: Higher Demand for Refrigeration Supported Results >002050.SZ

DJ

Lezen

22 dec 2025, 22:30 UTC

Winsten

Zhejiang Sanhua Intelligent Controls Sees 2025 Net CNY3.87B, Up 25% on Year >002050.SZ

DJ

Lezen

22 dec 2025, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

DJ

Lezen

22 dec 2025, 21:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

DJ

Lezen

22 dec 2025, 21:37 UTC

Acquisities, Fusies, Overnames

Capricorn: Project Is Contiguous to Capricorn's Golden Range, Fields Find Tenure

DJ

Lezen

22 dec 2025, 21:36 UTC

Acquisities, Fusies, Overnames

Capricorn to Pay A$500,000 Cash, A$4M in New Shares

DJ

Lezen

22 dec 2025, 21:35 UTC

Acquisities, Fusies, Overnames

Capricorn to Acquire Prospective Package From Tempest Minerals

DJ

Lezen

22 dec 2025, 21:35 UTC

Acquisities, Fusies, Overnames

Capricorn Metals to Buy Yalgoo Project Tenement Package for A$4.5M

DJ

Lezen

22 dec 2025, 20:54 UTC

Acquisities, Fusies, Overnames

Middle West Partners Buys Paul Stuart From Mitsui & Co.

DJ

Lezen

22 dec 2025, 20:52 UTC

Acquisities, Fusies, Overnames

HCL Technologies: HCLSoftware to Acquire Jaspersoft From Cloud Software Group >532281.BY

DJ

Lezen

22 dec 2025, 20:09 UTC

Marktinformatie

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

DJ

Lezen

22 dec 2025, 19:56 UTC

Marktinformatie

Crude Gains as U.S. Increases Actions Against Venezuela -- Market Talk

DJ

Lezen

22 dec 2025, 19:49 UTC

Acquisities, Fusies, Overnames

A Topsy-Turvy Year for Oracle and the Ellisons Will Bleed into 2026 -- Barrons.com

DJ

Lezen

22 dec 2025, 19:23 UTC

Marktinformatie

Mexico's Inflation Seen Easing in Early December -- Market Talk

DJ

Lezen

22 dec 2025, 19:23 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

DJ

Lezen

22 dec 2025, 19:02 UTC

Marktinformatie

Global Energy Roundup: Market Talk

DJ

Lezen

22 dec 2025, 19:02 UTC

Marktinformatie

Precious Metals Climb to New Heights -- Market Talk

DJ

Lezen

22 dec 2025, 18:45 UTC

Marktinformatie

Canadian Trade-Exposed Industries At Forefront of Job Weakness -- Market Talk

DJ

Lezen

22 dec 2025, 18:30 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Intersect Selling Portion of Assets as Part of Alphabet Deal -- Market Talk

DJ

Lezen

22 dec 2025, 18:23 UTC

Acquisities, Fusies, Overnames

What Yogi Berra Would Say About the Talks to Take Over Warner Bros. Discovery -- Barrons.com

DJ

Lezen

22 dec 2025, 17:20 UTC

Marktinformatie

Health Care Roundup: Market Talk

DJ

Lezen

22 dec 2025, 17:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

DJ

Lezen

22 dec 2025, 17:06 UTC

Acquisities, Fusies, Overnames

Alphabet to Buy Intersect for $4.75B as AI-Investment Plans Grow -- Update

DJ

Lezen

Peer Vergelijking

Prijswijziging

VIRIDIAN THERAPEUTICS INC Prognose

Koersdoel

By TipRanks

29.95% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 41.48 USD  29.95%

Hoogste 61 USD

Laagste 14.279 USD

Gebaseerd op 16 Wall Street-analisten die 12-maands prijsdoelen bieden voor VIRIDIAN THERAPEUTICS INC - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

16 ratings

16

Buy

0

Hold

0

Sell

Gebaseerd op 16 analisten die aandelenratings hebben gegeven aan VIRIDIAN THERAPEUTICS INC - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

12 / 13.14Steun & Weerstand

Korte Termijn

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Gemiddeld Termijn

Bearish Evidence

All events are bearish.

Lange Termijn

Strong Bearish Evidence

All events are bearish.

Sentiment

By Acuity

166 / 374 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Andere aandelen uit de sector

LLY

Eli Lilly and Co.

1,075.45

↑ +0.59%

JNJ

Johnson and Johnson

205.43

↓-0.83%

ABBV

AbbVie Inc

229.42

↑ +0.51%

UNH

UnitedHealth Group Inc

325.13

↓-0.09%

AZN

AstraZeneca PLC ADR

92.14

↑ +0.68%
help-icon Live chat